Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZZ) Construction in Progress (2023 - 2025)

Historic Construction in Progress for Core Scientific (CORZZ) over the last 3 years, with Q3 2025 value amounting to $688.7 million.

  • Core Scientific's Construction in Progress rose 34761.66% to $688.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $688.7 million, marking a year-over-year increase of 34761.66%. This contributed to the annual value of $162.9 million for FY2024, which is 1144.75% down from last year.
  • Per Core Scientific's latest filing, its Construction in Progress stood at $688.7 million for Q3 2025, which was up 34761.66% from $477.5 million recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Construction in Progress ranged from a high of $688.7 million in Q3 2025 and a low of $153.9 million during Q3 2024
  • Moreover, its 3-year median value for Construction in Progress was $230.3 million (2023), whereas its average is $323.9 million.
  • As far as peak fluctuations go, Core Scientific's Construction in Progress tumbled by 1144.75% in 2024, and later surged by 34761.66% in 2025.
  • Over the past 3 years, Core Scientific's Construction in Progress (Quarter) stood at $183.9 million in 2023, then decreased by 11.45% to $162.9 million in 2024, then surged by 322.89% to $688.7 million in 2025.
  • Its Construction in Progress was $688.7 million in Q3 2025, compared to $477.5 million in Q2 2025 and $276.8 million in Q1 2025.